Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Evaluation and treatment of dystonia Scott BLSouth Med J 2000[Aug]; 93 (8): 746-51BACKGROUND: Dystonia is a neurologic disorder that interferes with normal motor control, causing development of bizarre postures and writhing, twisting movements. METHODS: The patient database of the Duke Movement Disorders Clinic was searched to identify and characterize all cases of dystonia evaluated during the 3 1/2 year period between July 1995 and December 1998. RESULTS: Of the 68 patients identified, 44% had focal dystonia, 10% segmental dystonia, 9% hemidystonia, 7% generalized dystonia, 4% multifocal dystonia, 12% psychogenic dystonia, and 9% tardive dystonia. The remainder had either paroxysmal or pseudodystonia. Twenty-five patients had improvement with botulinum toxin injections, 16 with anticholinergics, benzodiazepines and/or baclofen, and 2 with tetrabenazine. CONCLUSION: A variety of treatments can give symptomatic benefit in dystonia, but appropriate treatment requires proper diagnosis of the condition.|Academic Medical Centers[MESH]|Adult[MESH]|Age of Onset[MESH]|Aged[MESH]|Diagnosis, Differential[MESH]|Disease Progression[MESH]|Dystonia/classification/*diagnosis/etiology/physiopathology/*therapy[MESH]|Dystonic Disorders/classification/*diagnosis/etiology/physiopathology/*therapy[MESH]|Humans[MESH]|Middle Aged[MESH]|Neuromuscular Agents/pharmacology/therapeutic use[MESH]|North Carolina[MESH] |